Europe's news in English

COPY LINK

HEALTH

Switzerland confirms first monkeypox case

Switzerland is among the latest countries to confirm a monkeypox case.

Published: 22 May 2022 16:05 CEST

Switzerland confirms first monkeypox case

Monkeypox transmission is usually via close contact with infected animals such as rodents and monkeys, and is limited between people. It has only been fatal in rare cases. Photo: Sanjay Kanojia/AFP

Switzerland is among the latest countries to confirm a case of monkeypox, identifying one infected person who had reportedly recently travelled abroad.

The confirmed case comes in the Bern canton and the infected traveller is receiving outpatient treatment and self-isolating, according to a statement published on Saturday. Close contacts have been informed through contact tracing.

More than 80 monkeypox cases have been confirmed in the outbreak across Europe, with the US, Canada, Australia, and Israel also confirming cases.

Monkeypox is most common in rural areas of Central and West Africa, and while human infection is not usually fatal it can manifest itself through fever, muscle aches, swollen lymph nodes, chills, exhaustion and a chickenpox-like rash on the hands and face.

Transmission is usually via close contact with infected animals such as monkeys. The recent outbreak has surprised medical experts as monkeypox was previously thought to rarely spread between humans. Health agencies across Europe have reiterated that the risk to the wider public is thought to be low.

READ ALSO What isn’t covered by Switzerland’s compulsory health insurance?

Member comments

Log in here to leave a comment.

Become a Member to leave a comment.

Which medications in Switzerland are set to become more expensive?

Swiss consumers pay significantly more for their medicines than those in neighbouring European countries.

This is what emerges from various data published over the years.

“In Switzerland, we pay far too much for medicines compared to abroad,” Matthias Müller, a spokesperson for SantéSuisse, an umbrella group for Swiss health insurance providers, told Swiss media in 2023.

Even the price of many generic medicines is twice as high in Switzerland as in nine EU countries.

For instance, generics are on average 48 percent cheaper in Belgium, Denmark, Germany, Finland, France, Great Britain, the Netherlands, Austria and Sweden than in Switzerland, according to a price comparison.

And prices for a number of commonly-used drugs will rise even further in the near future.

Why is that?

The Federal Office of Public Health (FOPH) is adapting a new model for calculating the distribution margin.

A distribution margin is the difference between the distributor’s cost of acquiring goods and the price at which those goods are sold.

From July 1st, 2024, inexpensive medicines whose factory price is less than, or equal to, 15 francs will become more expensive.

This change will affect more than half of medications currently being sold in Switzerland.

As a result of this move, “additional costs of several hundred million will be passed on to patients,” according to Intergenrika, which represents generic drug manufacturers in Switzerland.

In a nutshell, consumers will pay slightly lower prices for medicines that were previously more expensive, but will also end up paying more for those that are currently cheaper – like generics.

Which meds will become more expensive?

Pain medications are among those set to become pricier.

One of them is ibuprofen, a popular anti-inflammatory.

While a box of 20 400-mg tablets today costs 5.92 francs, its price will practically double to 11 francs from July 1st.

Though its manufacturing cost will remain the same as today – 1.58 francs – the distribution margin will increase from 4.19 to 9.09 francs.

The same goes for another often-used pain medication, Ponstan.

Ten 500-mg tablets will cost 11.21 francs instead of 6.19 currently.

The manufacturer will continue to charge 1.82 francs for the drug, but the distribution margin will increase from 4.22 to 9.11 francs.

And even generic drugs, which are cheaper – and often by much – will get pricier, at consumers’ expense.

Will some drugs be cheaper?

Yes, some will become slightly less expensive.

One example is the anticoagulant Rivaroxaban whose price will drop from 281 to 267 francs.

READ ALSO: Why you will pay more for certain drugs in Switzerland 2024?

Url copied to clipboard!